SCHEMBL10201175

SCHEMBL10201175

CC(C)(C)OC(=O)N1[C@@H]2CC2C[C@H]1c1nc2ccc(C#Cc3ccc(-c4cnc([C@@H]5C[C@H]6C[C@H]6N5C(=O)OC(C)(C)C)[nH]4)c(F)c3)cc2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.34
HCRTR1 O43613 5/20 0.32
HCRTR2 O43614 5/20 0.32
MLLT1 Q03111 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
HPGDS O60760 2/20 0.32
TBK1 Q9UHD2 1/20 0.31
BACE1 P56817 4/20 0.31
BACE2 Q9Y5Z0 2/20 0.31
CHEK2 O96017 1/20 0.31
CDK9 P50750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13221411 1.00 GPR119 (0.34) GPR119HCRTR1HCRTR2MLLT1GABRA1
SCHEMBL12406102 0.90 MLLT1 (0.37) HCRTR1HCRTR2MLLT1HPGDSTBK1
SCHEMBL13221409 0.89 HPGDS (0.36) HCRTR1HCRTR2GABRA1GABRG2GABRB3
SCHEMBL10201173 0.89 HPGDS (0.36) HCRTR1HCRTR2GABRA1GABRG2GABRB3
SCHEMBL13221410 0.84 HPGDS (0.34) GPR119HCRTR1HCRTR2GABRA1GABRG2
SCHEMBL10201179 0.84 HPGDS (0.34) GPR119HCRTR1HCRTR2GABRA1GABRG2
SCHEMBL12406068 0.82 HPGDS (0.39) HPGDSTBK1BACE1CHEK2
SCHEMBL10201134 0.82 USP30 (0.37) GPR119HCRTR1HCRTR2GABRA1GABRG2
SCHEMBL10182462 0.82 USP30 (0.37) GPR119HCRTR1HCRTR2GABRA1GABRG2
SCHEMBL12373650 0.80 HCRTR1 (0.33) HCRTR1HCRTR2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed